In recent years, scientists have developed monoclonal antibodies—proteins that mimic the body's own immune defenses—that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn's ...
Aug 30, 2021
0
65
Applying methods for analyzing road systems and rivers, researchers from the University of Copenhagen have studied the formation of the pancreatic network of ducts transporting digestive enzymes in mice. The network resembles ...
Aug 28, 2018
0
36
Studying gut bacteria can reveal a range of human illness. Now, new research shows that the composition of a person's intestinal bacteria could play an important role in the development of type 2 diabetes. These results, ...
Sep 26, 2012
6
0
Some health care professionals are growing concerned that amid the recent rush for the new highly effective, anti-obesity medications, patients are losing muscle as well as fat, which carries the risk that frailty will accompany ...
Mar 19, 2024
0
1
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ has found.
Feb 14, 2024
0
0
The biggest quandary in the obesity drug market is that nobody knows just how big it will be. Everyone agrees it'll be huge—currently, Eli Lilly & Co. is worth more than Tesla Inc., and Novo Nordisk A/S is at times the ...
Feb 12, 2024
0
1
State and local governments across the US are grappling with a growing problem: Expensive drugs to treat diabetes and obesity are threatening to drain their health care budgets.
Jan 9, 2024
0
5
Sibling death in childhood and early adulthood is associated with an increased risk for cardiovascular disease (CVD), according to a study published online Jan. 8 in JAMA Network Open.
Jan 8, 2024
0
0
A recent study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat type 2 diabetes and obesity, can lead to a rapid improvement ...
Jan 4, 2024
0
7
The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.
Jan 4, 2024
0
18
